Literature DB >> 1735182

Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice.

T Shibata1, T Berney, F Spertini, S Izui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1735182      PMCID： PMC1554266          DOI： 10.1111/j.1365-2249.1992.tb02973.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  32 in total

1.  Gamma globulin complexes in rheumatoid arthritis and certain other conditions.

Authors:  H G KUNKEL; H J MULLER-EBERHARD; H H FUDENBERG; T B TOMASI
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

Review 2.  Cryoimmunoglobulins.

Authors:  H M Grey; P F Kohler
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

3.  Studies on the cryoprecipitation of a human IGG3 cryoglobulin: the effects of temperature-induced comformational changes on the primary interaction.

Authors:  P H Saulk; W Clem
Journal:  Immunochemistry       Date:  1975-01

4.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides.

Authors:  S Izui; R A Eisenberg; F J Dixon
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

7.  Human monoclonal gamma G-cryoglobulins with anti-gamma-globulin activity.

Authors:  H M Grey; P F Kohler; W D Terry; E C Franklin
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

8.  Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome.

Authors:  J D Capra; H G Kunkel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Age-dependent production of IgA and IgM autoantibodies against IgG2a in a colony of 129/Sv mice.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307
View more
  6 in total

Review 1.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Cryoglobulins and the immunopathological manifestations of autoimmune disease.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 3.  Mechanisms of genetic control of murine systemic lupus erythematosus.

Authors:  S Izui; R Merino; M Iwamoto; L Fossati
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Further characterization of the autoantibody response of Palmerston North mice.

Authors:  B S Handwerger; C E Storrer; C S Wasson; F Movafagh; M Reichlin
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

5.  IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases.

Authors:  S Izui; T Berney; T Shibata; T Fulpius
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.

Authors:  Tomoko Ikeda; Hiroshi Fujii; Masato Nose; Yukiko Kamogawa; Tsuyoshi Shirai; Yuko Shirota; Tomonori Ishii; Hideo Harigae
Journal:  Arthritis Res Ther       Date:  2017-08-11       Impact factor: 5.156
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.